Over the last 34 years, hundreds of patents related to nanopolyphenols have been published (Rambaran, 2022)
The Science-First Product Narrative Supported by Acetylation S-Acetyl-L-glutathione provides brands with a powerful, science-based product narrative
Overuse concerns Frequent, high doses of IV therapy glutathione could interfere with the bodys natural production of antioxidants
J Clin Neurol 10(2):140147 Mora S, Wenger NK, Demicco DA, Breazna A, Boekholdt SM, Arsenault BJ, Deedwania P, Kastelein JJ, Waters DD (2012) Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study
"The companies and the FDA, no one's identified an endgame with these drugs," Kessler says